Stealth BioTherapeutics Corp (MITO) Stock Plunged 2.91% Pre-Market, Here’s Why
Stealth BioTherapeutics Corp (MITO) stock plummeted 2.91% in the pre-market trading session at the price of $1.00 after publishing its earnings report for the third quarter of 2021. MITO is a clinical-stage biotechnology firm that discovers, manufactures, and commercializes novel therapeutics to treat mitochondrial dysfunction. MITO Third Quarter 2021 Financial Results On 11th November 2021, MITO announced […]
Stealth BioTherapeutics Corp (MITO) Stock Plunged 2.91% Pre-Market, Here’s Why Read More »